top of page
Search

AbbVie manage to keep Humira Bx of Amgen out of US market till 2023 !

  • Writer: Sameer Agarwal
    Sameer Agarwal
  • Sep 28, 2017
  • 1 min read

As per information from various sources, AbbVie has signed a pact with Amgen which will ensure that Humira Bx will not be launched by Amgen in the US till 2023. However, Amgen can still launch the Humira Bx in the EU next year.


 
 
 
bottom of page